Randomized Study of Tesetaxel Plus Capecitabine vs Capecitabine Alone in Patients with HER2 Neg, HR+, Locally Advanced or Metastatic Brast Cancer Previously Treated with a Taxane (ODO-TE-B301)

Randomized Study of Tesetaxel Plus Capecitabine vs Capecitabine Alone in Patients with HER2 Neg, HR+, Locally Advanced or Metastatic Brast Cancer Previously Treated with a Taxane (ODO-TE-B301)

Trial Category:
Breast
Phase
III
Contact(s)
Mary Beth Wilwerding, RN
Phone
402-991-8070
Fax
402-991-8850
Location(s)
Nebraska Cancer Specialists, Omaha, NE
Nebraska Hematology Oncology, Lincoln, NE
Southeast Nebraska Cancer Center, Lincoln, NE
 
 
Become a NOS Member Today!
 

Platinum Corporate Members

Gold Corporate Members